2Tatou E,Charvre P.Long-term follow-up of anatomic heart transplantation. Apropos of 60 patients with a mean follow-up 36 months.Arch Mal Coeur Vaiss,1998,91:837-841.
3Polanco G,Jafri S M,Alam M, et al,Transesophageal echocardiographic findings in patients with orthotopic heart transplantation .Chest,1992,101:599-602.
5Moran A M,Lipshultz S E,Rifai N, et al.Non-invasive assessment of rejection in pediatric transplant patients :serologic and echocar- diographic prediction of biopsy-proven myocardial rejection. J Heart Lung Transplant, 2000,19:756-764.
6Valantine H A,Yech T C,Gibbons,et al.Sensitivity and specificity of Doppler indices for rejection surveillance temporal correlation with endomyocardial biopsy.J Heart Transplant,1991,9:81.
7Setengel S M,Allemann Y,Zimmerli M,et al.Doppler tissue imaging for assessing left ventricular diastolic dysfunction in heart transplant rejection.Heart,2001,86:432-437.
8Angermann C E,Nassau K,Stempfle H U, et al.Recognition of cardiac allograft rejection from serial integrated backscatter analyses in human orthotopic heart transplant recipients.Circulation,1997,95:140-150.
9Patel A R,Kuvin J T,Pandian N G,et al.Heart failure etiology affects periphral vascular endothelial function after cardiac transplantation.J Am Coll Cardiol,2001,37:195-200.
10Christoph H S,Volker K,Harald M,et al.Diagnostic and prognostic value of serial Dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy A comparison with coronary angiography and intravascular ultrasound .Circulation,1999,100:509-515.
二级参考文献16
1[2]Kitzman D W.Heart failure with normal systolic function.Clin Geriatr Med,2000,16(3):489-512.
2[3]Pinamnonti B,di Lenarda A,Sinagra G.Heart failure due to diastolic dysfunction:The treatment principles.Ital Heart J,2000,1(4 Suppl):469-480.
3[4]Zile M R,Nappi J.Diastolic heart failure.Curr Treat Options Cardiovasc Med,2000,2(5):439-450.
4[5]Mandinov L,Eberli F R,Seiler C,et al.Diastolic heart failure.Cardiovasc Res,2000,45:813-825.
5[6]Brown L,Duce B,Mitic G,et al.Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.J Am Soc Nephrol,1999,11(5):S143-148.
6[7]Brilla C G,Funck R C,Rupp H.Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.Circulation,2000,102(12):1342-1345.
7[8]Warner J G Jr,Metzger D C,Kitzman D W,et al.Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise.J Am Coll Cardiol,1999,33(6):1567-1572.
8[9]Sun Y,Weber K T.Infarct scar:A dynamic tissue.Cardiovasc Res,2000,46(2):250-256.
9[10]Verdecchia P,Schillaci G,Reboldi G P,et al.Long-term effects of losartan and enalapril,allone or with a diuretic on ambulatory blood pressure and cardiac performance in hypertension:A case-control study.Blood Press Monit,2000,5(3):187-193.
10[11]Liu Y H,Yang X P,Mehta D,et al.Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.Am J Physiol Heart Circ Physiol,2000,278(2):H507-514.
